The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Mesoporous Silica Nanomaterial-Based Biotechnological and Biomedical Delivery Systems
Abstract
This review details the recent advancements in the design of mesoporous silica nanomaterials for controlled release drug, gene and neurotransmitter delivery applications. The high surface area (>900 m2/g), tunable pore diameter (2-20 nm) and uniform mesoporous structure (hexagonal channels or cubic pores) of the mesoporous silicas offer a unique advantage for loading and releasing large quantities of biomedical agents. Recent breakthroughs in controlling the particle size and shape of these materials have greatly improved the biocompatibility and the cellular uptake efficiency. The strategy of using various removable capping moieties, such as photo- or redox-responsive organic groups, inorganic nanoparticles, dendrimers and polymers, to encapsulate guest biomolecules inside the porous matrices further enables the utilization of these surface-functionalized mesoporous silica nanomaterials for stimuli-responsive controlled release in vitro and in vivo. In addition to the reviewed studies, many new and exciting applications of these novel materials will soon be realized.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Polymeric systems for controlled drug release
Uhrich, K. E., Cannizzaro, S. M., Langer, R. S., & Shakesheff, K. M. (1999) · Chemical Reviews · doi:10.1021/cr940351u · Cited by 2,633 · cited 1×
“This is very different from the biodegradable polymer-based drug-delivery systems, in which the release of drugs often relies on hydrolysis-induced structure degradation of the carriers, which leads to the undesirable structural or functional modifications, or both, of the encapsulated molecules [52–54].”
BackgroundMultifunctional polymeric micelles as cancer-targeted, MRI-ultrasensitive drug delivery systems
Nasongkla, N., Bey, E., Ren, J., Ai, H., Khemtong, C., Guthi, J. S., Chin, S.-F., Sherry, A. D., Boothman, D. A., & Gao, J. (2006) · Nano Letters · doi:10.1021/nl061412u · Cited by 1,238
Cited by
Engineered Nanoparticles for Drug Delivery in Cancer Therapy
Sun, T., Zhang, Y. S., Pang, B., Hyun, D. C., Yang, M., & Xia, Y. (2014) · Angewandte Chemie International Edition · doi:10.1002/anie.201403036 · Cited by 2,164
Mesoporous silica nanoparticles in drug delivery and biomedical applications
Wang, Y., Zhao, Q., Han, N., Bai, L., Li, J., Liu, J., Che, E., Hu, L., Zhang, Q., Jiang, T., et al. (2015) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2014.09.014 · Cited by 1,192
Size Effect on Cell Uptake in Well‐Suspended, Uniform Mesoporous Silica Nanoparticles
Lu, F., Wu, S., Hung, Y., & Mou, C. (2009) · Small · doi:10.1002/smll.200900005 · Cited by 1,041
Nanomedicine(s) under the Microscope
Duncan, R., & Gaspar, R. (2011) · Molecular Pharmaceutics · doi:10.1021/mp200394t · Cited by 981
Huang, X., Li, L., Liu, T., Hao, N., Liu, H., Chen, D., & Tang, F. (2011) · ACS Nano · doi:10.1021/nn200365a · Cited by 921
Rosenholm, J. M., Sahlgren, C., & Lindén, M. (2010) · Nanoscale · doi:10.1039/c0nr00156b · Cited by 572
Mesoporous silica nanoparticles for bioadsorption, enzyme immobilisation, and delivery carriers
Popat, A., Hartono, S. B., Stahr, F., Liu, J., Qiao, S. Z., & Qing (Max) Lu, G. (2011) · Nanoscale · doi:10.1039/c1nr10224a · Cited by 548
Targeting of Porous Hybrid Silica Nanoparticles to Cancer Cells
Rosenholm, J. M., Meinander, A., Peuhu, E., Niemi, R., Eriksson, J. E., Sahlgren, C., & Lindén, M. (2009) · ACS Nano · doi:10.1021/nn800781r · Cited by 520
Current applications of nanoparticles in infectious diseases
Zazo, H., Colino, C. I., & Lanao, J. M. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.01.008 · Cited by 434
Wang, H., Jeong, H. Y., Imura, M., Wang, L., Radhakrishnan, L., Fujita, N., Castle, T., Terasaki, O., & Yamauchi, Y. (2011) · Journal of the American Chemical Society · doi:10.1021/ja2058617 · Cited by 403
Synthesis and biomedical applications of aerogels: Possibilities and challenges
Maleki, H., Durães, L., García-González, C. A., del Gaudio, P., Portugal, A., & Mahmoudi, M. (2016) · Advances in Colloid and Interface Science · doi:10.1016/j.cis.2016.05.011 · Cited by 386
Knopp, D., Tang, D., & Niessner, R. (2009) · Analytica Chimica Acta · doi:10.1016/j.aca.2009.05.037 · Cited by 380
Bioconjugated silica nanoparticles: Development and applications
Wang, L., Zhao, W., & Tan, W. (2008) · Nano Research · doi:10.1007/s12274-008-8018-3 · Cited by 378
Aerosol Route to Functional Nanostructured Inorganic and Hybrid Porous Materials
Boissiere, C., Grosso, D., Chaumonnot, A., Nicole, L., & Sanchez, C. (2011) · Advanced Materials · doi:10.1002/adma.201001410 · Cited by 366
Schlossbauer, A., Kecht, J., & Bein, T. (2009) · Angewandte Chemie International Edition · doi:10.1002/anie.200805818 · Cited by 299
Clemens, D. L., Lee, B.-Y., Xue, M., Thomas, C. R., Meng, H., Ferris, D., Nel, A. E., Zink, J. I., & Horwitz, M. A. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.06049-11 · Cited by 260
Metadata
- Authors
- Giri, S., Trewyn, B. G., & Lin, V. S.
- Venue
- Nanomedicine
- Publisher
- Informa UK Limited
- Published
- 2007-02
- Volume
- 2
- Issue
- 1
- Pages
- 99-111
- ISSN
- 1743-5889 (ISSN-L)
- 1748-6963
- OpenAlex
- W2142429646
- Cited by
- 159
- References
- 2
- FWCI
- 6.95
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.